Close Menu

Move It Around

While a Senate proposal will shrink the US National Science Foundation's 2012 by $162 million, it may give the agency some flexibility on how to spend that money, reports ScienceInsider. The Senate Appropriations Committee voted last week to allot $6.7 billion to NSF for fiscal year 2012 and the lawmakers are considering allowing NSF to shift $100 million from its research budget to its facilities budget.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.